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A B S T R A C T
A 33-year-old male patient with fever, splenomegaly, pancytopenia and lymphocyto-
sis was admitted to the Department of Hematology in Rijeka. Laboratory findings, bone
marrow aspiration and biopsy excluded hemoblastosis and aplastic anemia. To exclude
primary splenic lymphoma we performed splenic aspiration where Leishmania amasti-
gotes were found. No cases of visceral leishmaniasis have been previously described in
the Northern Adriatic region. Considering epidemiology, a contraction of the disease in
the Velebit mountain range could be possible despite the current non-endemic status of
the region.
Introduction
The leishmaniases are a group of dis-
eases caused by the genus Leishmania
and transmitted by female sandflies of
the genus Phlebotomus in the Old World
and Lutzomyia in the New World. Hu-
man leishmanial infection can result in
three main forms of disease: visceral form
(Kala-azar), cutaneous disease and muco-
cutaneous leishmaniasis1,2. Visceral leish-
maniasis is the most serious, potentially
fatal form of the disease which has a
worldwide distribution. Certain regions
are endemic areas of the disease includ-
ing the countries of Europe, North Africa
and the Middle East surrounding the
Mediterranean basin3,4. Endemic regions
in Croatia include middle and southern
Dalmatia, but the disease remains spo-
radic. The Northern Adriatic has been
considered a non-endemic region. The or-
ganisms causing visceral leishmaniasis
in the Mediterranean region (L. infan-
tum) and those in Americas (L. chagasi)
are very similar and the disease is mainly
characterized by fever, weight loss, hepa-
tosplenomegaly, lymphadenopathy and
pancytopenia. Routine diagnostic proce-
dures include several serological methods
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and microscopic examination of Giemsa-
-stained material obtained from the bone
marrow, lymph nodes or spleen. Most
commonly used drugs in the treatment of
visceral leishmaniasis are pentavalent
antimony compounds.
Case Report
A previously healthy, 33-year-old male
patient was admitted to the Department
of Hematology, University Hospital Center
»Rijeka«, presenting with remittent fever
which lasted for two months, weakness,
hepatosplenomegaly and pancytopenia.
On admission he was febrile (38.5 °C), the
liver was palpable 1 cm and the spleen 5
cm below the costal margin.
Laboratory tests revealed elevated
ESR, pancytopenia and mild lympho-
cytosis with atypical cells in the periph-
eral blood (Table 1). Total serum proteins
were raised (93 g/L), albumins 39.1 g/L,
gamma globulins 36.4 g/L. Serum proth-
rombine time was prolonged to 19 sec-
onds. Lactate dehydrogenase (LDH) was
elevated (505 IU/L).
The patient remained febrile for 15
days with his body temperature showing
a remittent pattern. Repeated blood cul-
tures were negative as well as Vidal's re-
action. Malaria was excluded by exami-
nation of thick and thin blood films.
Broad spectrum antibiotic therapy admi-
nistered during the diagnosing process
included Cefuroxime 3 750 mg/day i.v.
and Netilmycin 2 150 mg/day i.v. for 5
days followed by Imipenem 3 1 g/day i.v.
for 7 days, but remained sine effectu.
Clinically non-progressive splenic en-
largement (200 mm) was visualized and
measured by abdominal ultrasound which
also showed an enlarged liver. Bone mar-
row aspiration, ordered to exclude aleu-
kemic leukemia and malignant non-Hodg-
kin's lymphoma, revealed only mild
plasmocytosis (7.5%) (Figure 1), while
Leishmania amastigotes could be found
neither in the bone marrow aspirate nor
in the bone marrow biopsy specimen.
The patient's condition worsened with
persisting fever accompanied by sweats
and discomfort in the left hypochondri-
um. In order to exclude primary splenic
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TABLE 1









ESR (mm/h) 98 35 9
E ( 1012/l) 3.7 4 4.8
Hb (g/L) 98 118 141
WBC ( 109/L) 2.2 4.2 6.6
Lymphocytes (%) 44 40 39
Platelets ( 109/L) 62 205 297
dctlparPlasma cells (%) 4 0 0
Atypical cells (%) 13 2 1
Blast cells (%) 2 0 0
Total serum proteins (g/L) 93 – 80
Albumins (g/L) 39.1 – 44
Gamma globulins (g/L) 36.4 – 14
LDH (IU/L) 505 382 195
lymphoma we decided to do splenic aspi-
ration biopsy. Unexpectedly, Leishmania
amastigotes were found in the splenic as-
pirate (Figure 2), but not in the bone mar-
row aspirate and biopsy specimens. Immu-
nofluorescent assay (IFA) for Leishmania
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Fig. 1. Bone marrow plasmocytosis – aspiration biopsy smear
( 1000, May-Grünwald-Giemsa stain).
Fig. 2. Leishmania amastigotes in the splenic aspirate
( 1000, May-Grünwald-Giemsa stain).
showed an IgG titre of 1:2560 and the
Formol gel reaction was also positive.
A repeated analysis of the epidemio-
logical history indicated that the patient
resided in a military setting located in
the non-endemic region of the Velebit
mountain range (Northern Adriatic) for
two years and 4 months.
Treatment was initiated with Pento-
stam (pentavalent antimony derivate)
850 mg/day for 21 days. On the third day
of Pentostam therapy the body tempera-
ture fell to the normal value and the pa-
tient's condition continued to improve.
On the 12th day of Pentostam therapy the
patient got Staphylococcus aureus pneu-
monia. Ceftriaxon therapy was adminis-
tered and the body temperature normal-
ized after three days. Our patient left the
hospital after 50 days of hospitalization,
feeling very well and being afebrile. The
spleen was palpable 1 cm below the costal
margin. We registered an improvement
in the laboratory findings: ESR 35 mm/h,
WBC 4 109/L, lymphocytes 40%, LDH
382 U/L, atypical cells 2%, blast cells dis-
appeared. IFA IgG antibody titre to Leis-
hmania was 1:256 six months after the
diagnosis was made. However, after one
year the spleen was not palpable and the
laboratory tests were normal (Table 1).
Discussion
A certain protraction of this patient's
diagnostic process has been partly caused
by previous diagnostics which ruled out
most of the epidemiological problems and
infectious diseases in the mountainous
region of Velebit and contemporary mili-
tary setting where the patient spent two
years and four months prior to the admis-
sion to our Department of Hematology.
Other non-hematological disorders were
also considered, shifting our attention to
the possible hematological causes of the
leading symptoms. Therefore, our diag-
nostic algorithm was targeted to exclude
hemoblastosis, lymphoma or aplastic
anemia primarily, despite the fact that fe-
ver, splenomegaly and pancytopenia were
also attributable to visceral leishmani-
asis. In addition to a number of more fre-
quent disorders, especially within the
chronically stressed populations in the
post-war years, an atypical epidemiologi-
cal history and non-endemic status of the
Velebit mountain range, certainly affec-
ted our diagnostic algorithm in this unex-
pected case.
Conventional approaches to the diag-
nosis of visceral leishmaniasis include
several serological methods and micro-
scopic examinations of the material ob-
tained from the bone marrow, lymph no-
des and spleen. The bone marrow may be
infiltrated with parasitized macrophages
which usually rupture on smearing and
free parasites must be searched. In this
case, laboratory examination, as well as
bone marrow aspiration and biopsy, ex-
cluded hemoblastosis but no Leishmania
amastigotes were found. To rule out pri-
mary splenic lymphoma we considered
spleen biopsy which is also a diagnostic
procedure in visceral leishmaniasis. Al-
though the examination of the material
obtained from the spleen detects para-
sites in 95–99% of cases1,2, splenic aspira-
tion is an invasive procedure with hemor-
rhage as its possible complication. Follo -
wing our criteria for the spleen aspiration
biopsy (prothrombin time preferably
within normal values or less than 5 sec-
onds longer than in the normal control
(10–14s), and platelet count not less than
80 109/L), in order to optimize the safety
of the procedure, K vitamin and platelet
transfusions were administered prior to
the splenic aspiration. We were surprised
to find Leishmania amastigotes in the
spleen macrophages since there were no
parasitized cells found in the bone mar-
row specimens which might have also
been diagnostic for the disease. In this
case, splenic aspiration biopsy was the
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key diagnostic procedure, confirmed later
by serological tests.
In the past two decades there has been
a resurgence of visceral leishmaniasis in
the regions where it was eradicated after
the widespread use of chlorophenothane
(DDT) in malaria prevention. Phleboto-
mine populations were greatly reduced
around houses but zoonotic transmission
was not affected. When the use of resid-
ual insecticides was discontinued in ma-
ny Mediterranean countries, transmis-
sion to people was reestablished with an
increase in the number of leishmania
cases4. Rare autochthonous cases of vis-
ceral leishmaniasis in the middle and
southern Dalmatia have recently been
described in literature5,6, as well as cases
of imported visceral leishmaniasis from
southern Croatia into the neighboring
countries. However, these sporadic cases
hardly represented a significant public
health problem7, even in the endemic re-
gions. There have been no leishmania
cases reported in the northwestern, litto-
ral part of the Adriatic coast where the
infection is considered extremely rare
and the region non-endemic. However,
outbreaks of visceral leishmaniasis have
often followed famine, wars, civil and po-
litical disturbances resulting in malnutri-
tion and migration of populations. It is
also necessary to underline the existing
differences in the clinical course of the
disease: some infected individuals de-
velop subclinical infection and others
clinical disease. Reasons responsible for
differences in the outcome of infection are
not known, but possible factors include:
variations in the species of parasite and
the intensity of transmission, nutritional
status of the patient (malnourished in-
fected children develop clinical disease,
while equally exposed well-nourished
children develop subclinical infection), or
combinations of these or other factors.
According to the epidemiological data
in the medical history of our patient and
the usual length of the incubation period,
there is strong ground to suspect an
autochthonous infection in this region, al-
though the possibility of a previously ac-
quired infection with a long incubation
period and clinical manifestation of the
disease after more than three years spent
in a chronically stressful, non-endemic
environment, cannot be completely ruled
out. A combination of factors including
stress, malnutrition and a modified im-
mune response might have played an im-
portant role in any of these scenarios.
Considering the changes in climate,
higher temperatures are likely to acceler-
ate maturation of the protozoal parasite,
thereby increasing the risk of infection.
The spread of vectors from the adjacent
southern regions seems logical, although
multidisciplinary studies onsite should
backup these speculations in the futu-
re7–11. In addition to the changes in mi-
croclimate, it would be interesting to in-
vestigate possible changes in the distri-
bution and relations between reservoirs
and vectors responsible for the transmis-
sion of the disease. Future studies of the
medically relevant entomofauna, not ade-
quately investigated in Croatia7, could
concentrate on the possible spread of
sandflies along the northern coast and
adjacent mountains, which would con-
firm the possibility of the autochthonous
acquisition of the disease in the Velebit
region.
Considering the increased number of
autochthonous and imported cases of vis-
ceral leishmaniasis8–14, its chronic clini-
cal course and a high mortality rate if not
recognized, pancytopenia, splenomegaly
and fever should be timely associated and
serologically tested for visceral leishma-
niasis even in non-endemic regions, and
during diagnostic efforts reasonably
aimed at non-infective diseases of similar
presentation. The importance of the epi-
demiological history and continuous eval-
uations is crucial15, therefore, this case
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and the emerging reports raise a consid-
erable amount of questions for both,
epidemiologists and clinicians, to be an-
swered by the future analyses that might
help reconsider the leishmania endemic
regions in Croatia.
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PRIKAZ SLU^AJA VISCERALNE LI[MENIOZE NA PODRU^JU
SJEVERNOG JADRANA
S A @ E T A K
Na Hematolo{kom odjelu u Rijeci hospitaliziran je 33-godi{nji mu{karac zbog po-
vi{ene temperature, splenomegalije, pancitopenije i limfocitoze. Laboratorijski nalazi,
punkcija i biopsija ko{tane sr`i isklju~ili su hemoblastozu i aplasti~nu anemiju. Zbog
sumnje na primarni limfom slezene, u~injena je aspiracijska biopsija slezene te su u
makrofagima prona|eni amastigoti li{menije. Do sada nije opisan slu~aj pojave vis-
ceralne li{menioze na podru~ju sjevernog Jadrana, iako se ista javlja endemski u sred-
njoj i ju`noj Dalmaciji. Prema epidemiolo{koj anamnezi, mogu}a je infestacija na po-
dru~ju Velebita.
